People with HIV express high satisfaction with monthly injectable regimen
HIV capsid inhibitor may offer long-term viral suppression
Long-acting injectable treatment maintains viral suppression
Removable PrEP implant produces high drug levels in rabbits; further studies planned
Prolonged HIV suppression is possible using ibalizumab, analysis of highly drug-resistant people shows
Beyond Truvada – what is the future of PrEP?
First large HIV prevention trial using antibodies will probably not be the last
The long tail of injectable PrEP is especially long for women
